Status:
TERMINATED
Pilot Study of VTI Doppler Probe Use to Identify Neurovascular Bundle During Prostate Surgery
Lead Sponsor:
Columbia University
Conditions:
Prostate Cancer
Nerve Sparing Prostatectomy
Eligibility:
MALE
18+ years
Phase:
NA
Brief Summary
This study is designed to evaluate the use of a disposable laparoscopic Doppler probe in robotic assisted prostatectomies. The Vascular Technology, Inc. (VTI) laparoscopic probe is simply a sterile, d...
Detailed Description
The VTI Laparoscopic Doppler System is a blood flow detector that compensates for the loss of tactile sensation during laparoscopic procedures by helping the surgeon to identify vascular anatomy befor...
Eligibility Criteria
Inclusion
- All patients must be 18 years of age or older and be able to read, understand and sign consent.
- Any patient undergoing robotic assisted laparoscopic prostatectomy (RALP)
- Any patient without moderate or severe erectile dysfunction (SHIM less than 15) undergoing bilateral or unilateral nerve-sparing RALP is eligible for this procedure.
Exclusion
- Patients undergoing a non nerve-sparing RALP will be excluded from this study
- Those who receive a baseline SHIM score less than 15
Key Trial Info
Start Date :
August 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2012
Estimated Enrollment :
9 Patients enrolled
Trial Details
Trial ID
NCT01794936
Start Date
August 1 2011
End Date
April 1 2012
Last Update
May 29 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Columbia University Medical Center
New York, New York, United States, 10032